Literature Highlights
Muller, P. A., and Vousden, K. H. (2014).
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities. Cancer Cell 25(3), 304-317.
Supek, F., Minana, B., Valcarcel, J., Gabaldon, T., and Lehner, B. (2014).
Synonymous mutations frequently act as driver mutations in human cancers. Cell 156, 1324-1335.
Hoe, K. K., Verma, C. S., and Lane, D. P. (2014).
Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov 13, 217-236.